Biomea Fusion IncNASDAQ:BMEA
- LAST PRICE11.8400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.0700/ 1
- Ask / Lots12.0000/ 1
- Open / Previous Close0.0000 / 11.8400
- Day Range---
- 52 Week Range
- Volume9
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMEA |
|---|---|---|
| 09:32 ET | 9200 | 11.06 |
| 09:34 ET | 2854 | 10.8301 |
| 09:36 ET | 855 | 10.78 |
| 09:38 ET | 1385 | 10.7 |
| 09:39 ET | 1439 | 10.695 |
| 09:41 ET | 200 | 10.8 |
| 09:43 ET | 600 | 10.805 |
| 09:45 ET | 200 | 10.79 |
| 09:48 ET | 239 | 10.87 |
| 09:50 ET | 1091 | 10.775 |
| 09:52 ET | 1428 | 10.82 |
| 09:54 ET | 872 | 10.8 |
| 09:57 ET | 1250 | 10.84 |
| 09:59 ET | 416 | 10.8725 |
| 10:01 ET | 1514 | 10.93 |
| 10:06 ET | 200 | 10.92 |
| 10:10 ET | 200 | 10.86 |
| 10:14 ET | 1272 | 10.89 |
| 10:15 ET | 628 | 10.86 |
| 10:17 ET | 1020 | 10.86 |
| 10:19 ET | 2942 | 11.02 |
| 10:21 ET | 100 | 11.02 |
| 10:24 ET | 1575 | 11 |
| 10:26 ET | 300 | 11.05 |
| 10:28 ET | 450 | 11.06 |
| 10:30 ET | 500 | 11.095 |
| 10:32 ET | 450 | 11.1 |
| 10:33 ET | 1803 | 11.1235 |
| 10:35 ET | 8234 | 11.1201 |
| 10:37 ET | 2379 | 11.17 |
| 10:39 ET | 2086 | 11.235 |
| 10:42 ET | 3358 | 11.28 |
| 10:46 ET | 924 | 11.24 |
| 10:48 ET | 500 | 11.29 |
| 10:50 ET | 17309 | 11.35 |
| 10:51 ET | 200 | 11.28 |
| 10:53 ET | 631 | 11.22 |
| 10:55 ET | 1082 | 11.1 |
| 10:57 ET | 200 | 11.1 |
| 11:00 ET | 2123 | 11.13 |
| 11:02 ET | 300 | 11.18 |
| 11:04 ET | 850 | 11.17 |
| 11:08 ET | 100 | 11.155 |
| 11:09 ET | 300 | 11.15 |
| 11:11 ET | 100 | 11.16 |
| 11:13 ET | 2066 | 11.11 |
| 11:15 ET | 1172 | 11.12 |
| 11:18 ET | 1127 | 11.13 |
| 11:20 ET | 300 | 11.12 |
| 11:22 ET | 200 | 11.14 |
| 11:24 ET | 720 | 11.21 |
| 11:26 ET | 208 | 11.21 |
| 11:27 ET | 100 | 11.215 |
| 11:29 ET | 311 | 11.2 |
| 11:31 ET | 200 | 11.22 |
| 11:36 ET | 100 | 11.18 |
| 11:38 ET | 100 | 11.19 |
| 11:40 ET | 400 | 11.2 |
| 11:45 ET | 1400 | 11.25 |
| 11:47 ET | 375 | 11.24 |
| 11:51 ET | 400 | 11.26 |
| 11:54 ET | 500 | 11.25 |
| 11:56 ET | 3800 | 11.265 |
| 11:58 ET | 600 | 11.28 |
| 12:00 ET | 1861 | 11.3 |
| 12:02 ET | 175 | 11.3 |
| 12:03 ET | 200 | 11.27 |
| 12:05 ET | 100 | 11.26 |
| 12:07 ET | 100 | 11.275 |
| 12:09 ET | 1400 | 11.3 |
| 12:14 ET | 1111 | 11.29 |
| 12:16 ET | 678 | 11.29 |
| 12:18 ET | 100 | 11.25 |
| 12:20 ET | 3680 | 11.29 |
| 12:21 ET | 6234 | 11.3201 |
| 12:23 ET | 400 | 11.335 |
| 12:27 ET | 400 | 11.33 |
| 12:30 ET | 1752 | 11.4 |
| 12:32 ET | 760 | 11.41 |
| 12:36 ET | 335 | 11.39 |
| 12:38 ET | 600 | 11.42 |
| 12:39 ET | 300 | 11.41 |
| 12:41 ET | 1344 | 11.48 |
| 12:43 ET | 3251 | 11.5 |
| 12:45 ET | 500 | 11.52 |
| 12:48 ET | 1050 | 11.5101 |
| 12:50 ET | 979 | 11.45 |
| 12:52 ET | 668 | 11.43 |
| 12:56 ET | 200 | 11.47 |
| 12:57 ET | 2900 | 11.42 |
| 12:59 ET | 100 | 11.43 |
| 01:01 ET | 585 | 11.4 |
| 01:03 ET | 100 | 11.4 |
| 01:06 ET | 134 | 11.4 |
| 01:08 ET | 1158 | 11.395 |
| 01:10 ET | 10237 | 11.35 |
| 01:12 ET | 318 | 11.35 |
| 01:14 ET | 1262 | 11.33 |
| 01:15 ET | 827 | 11.41 |
| 01:24 ET | 9800 | 11.45 |
| 01:26 ET | 722 | 11.47 |
| 01:28 ET | 250 | 11.46 |
| 01:30 ET | 7343 | 11.4 |
| 01:32 ET | 150 | 11.415 |
| 01:33 ET | 200 | 11.41 |
| 01:35 ET | 550 | 11.405 |
| 01:37 ET | 1200 | 11.405 |
| 01:39 ET | 1220 | 11.41 |
| 01:42 ET | 300 | 11.42 |
| 01:44 ET | 742 | 11.41 |
| 01:46 ET | 500 | 11.42 |
| 01:48 ET | 500 | 11.41 |
| 01:53 ET | 1793 | 11.42 |
| 01:55 ET | 386 | 11.43 |
| 01:57 ET | 535 | 11.43 |
| 02:00 ET | 1400 | 11.38 |
| 02:02 ET | 700 | 11.3799 |
| 02:06 ET | 6552 | 11.38 |
| 02:08 ET | 318 | 11.36 |
| 02:09 ET | 100 | 11.35 |
| 02:13 ET | 1000 | 11.35 |
| 02:15 ET | 1323 | 11.39 |
| 02:18 ET | 942 | 11.37 |
| 02:20 ET | 300 | 11.3685 |
| 02:24 ET | 1858 | 11.3715 |
| 02:26 ET | 200 | 11.4 |
| 02:29 ET | 662 | 11.39 |
| 02:33 ET | 1400 | 11.42 |
| 02:38 ET | 200 | 11.42 |
| 02:40 ET | 4345 | 11.5001 |
| 02:42 ET | 1475 | 11.5031 |
| 02:45 ET | 628 | 11.48 |
| 02:47 ET | 1943 | 11.43 |
| 02:49 ET | 243 | 11.41 |
| 02:51 ET | 1244 | 11.42 |
| 02:56 ET | 1120 | 11.47 |
| 02:58 ET | 300 | 11.47 |
| 03:00 ET | 100 | 11.48 |
| 03:02 ET | 1536 | 11.49 |
| 03:03 ET | 1400 | 11.441 |
| 03:05 ET | 400 | 11.45 |
| 03:07 ET | 400 | 11.46 |
| 03:09 ET | 418 | 11.45 |
| 03:12 ET | 400 | 11.44 |
| 03:14 ET | 850 | 11.39 |
| 03:16 ET | 1196 | 11.37 |
| 03:18 ET | 1000 | 11.35 |
| 03:20 ET | 1447 | 11.35 |
| 03:21 ET | 12247 | 11.46 |
| 03:25 ET | 666 | 11.43 |
| 03:27 ET | 1094 | 11.401 |
| 03:30 ET | 2467 | 11.41 |
| 03:32 ET | 100 | 11.41 |
| 03:34 ET | 700 | 11.45 |
| 03:36 ET | 1758 | 11.47 |
| 03:38 ET | 1563 | 11.47 |
| 03:39 ET | 1761 | 11.555 |
| 03:41 ET | 23819 | 11.6 |
| 03:43 ET | 19828 | 11.69 |
| 03:45 ET | 3811 | 11.67 |
| 03:48 ET | 10426 | 11.77 |
| 03:50 ET | 2380 | 11.79 |
| 03:52 ET | 12179 | 11.83 |
| 03:54 ET | 6158 | 11.8 |
| 03:56 ET | 11738 | 11.85 |
| 03:57 ET | 37446 | 11.92 |
| 03:59 ET | 42829 | 11.84 |
Jun 3, 2024
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones
4:05PM ET on Monday Jun 03, 2024 by Dow Jones
May 30, 2024
DJ Biomea Fusion Is Maintained at Outperform by Oppenheimer, from 10:34AM ET on Thursday May 30, 2024 by Dow Jones
10:34AM ET on Thursday May 30, 2024 by Dow JonesBiomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes, from 9:12AM ET on Thursday May 30, 2024 by Dow Jones
9:12AM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomea Fusion Inc | 378.1M | -3.3x | --- |
enGene Holdings Inc | 387.6M | -1.7x | --- |
Terns Pharmaceuticals Inc | 388.7M | -5.5x | --- |
LENZ Therapeutics Inc | 390.4M | -1.0x | --- |
Aura Biosciences Inc | 364.1M | -4.0x | --- |
Fibrobiologics Inc | 398.5M | -6.5x | --- |
Company Information
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Contact Information
- Headquarters
- 900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
- Phone
- 650-980-9099
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Thomas Butler
- President, Co-Founder, Chief Operating Officer, Director
- Rainer Erdtmann
- Chief Financial Officer
- Franco Valle
- Chief Medical Officer
- Juan Fras
- Chief Development Officer
- Steve Morris
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $378.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
